Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study
- Dufour, Jean-François
- Hoppe, Hanno
- Heim, Markus H
- Helbling, Beat
- Maurhofer, Olivier
- Szucs-Farkas, Zsolt
- Kickuth, Ralph
- Borner, Markus
- Candinas, Daniel
- Saar, Bettina
Publication date
January 2010
DOI Publisher
Alphamed Press ISSN
1083-7159 Citation count (estimate)
64Abstract
It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma. This study assesses the safety and tolerability of a continuous regimen of sorafenib combined with TACE
Add to ORKG